John Overdeck’s Edwards Lifesciences EW Stock Holding History

John Overdeck’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.24M	Sell	13,700 -1,800	-12%	-$151K	﹤0.01%	3446
2026 Q1	$1.24M	Buy	+15,500	New	+$1.28M	﹤0.01%	3097
2022 Q1	–	Sell	-4,700	Closed	-$609K	–	3187
2021 Q4	$609K	Sell	4,700 -300	-6%	-$35K	﹤0.01%	3047
2021 Q3	$566K	Hold	5,000	–	–	﹤0.01%	3142
2021 Q2	$518K	Buy	+5,000	New	+$471K	﹤0.01%	3068
2021 Q1	–	Sell	-5,400	Closed	-$493K	–	3937
2020 Q4	$493K	Buy	+5,400	New	+$448K	﹤0.01%	2527
2020 Q3	–	Sell	-5,100	Closed	-$352K	–	3218
2020 Q2	$352K	Buy	+5,100	New	+$362K	﹤0.01%	2269
2020 Q1	–	Sell	-24,600	Closed	-$1.91M	–	3312
2019 Q4	$1.91M	Buy	24,600 +13,500	+122%	+$1.05M	0.01%	1621
2019 Q3	$814K	Buy	11,100 +5,100	+85%	+$358K	﹤0.01%	2157
2019 Q2	$369K	Buy	+6,000	New	+$363K	﹤0.01%	2727
2018 Q3	–	Sell	-34,800	Closed	-$1.69M	–	3281
2018 Q2	$1.69M	Buy	+34,800	New	+$1.62M	0.01%	1751
2016 Q4	–	Sell	-15,900	Closed	-$639K	–	3211
2016 Q3	$639K	Buy	+15,900	New	+$599K	﹤0.01%	2286
2015 Q3	–	Sell	-12,000	Closed	-$285K	–	2336
2015 Q2	$285K	Hold	12,000	–	–	﹤0.01%	2457
2015 Q1	$285K	Buy	+12,000	New	+$269K	﹤0.01%	2299

Other funds holding EW

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

John Overdeck's EW Position: Q2 2026 in Review

John Overdeck increased its Edwards Lifesciences (EW) stake by 45% in Q2 2026, buying an estimated $39.4M and bringing the position to 1,521,899 shares worth $138M. The position accounts for 0.1% of the portfolio, ranked #225.

John Overdeck first reported a position in EW in Q3 2013 and has held it in 42 quarters since. The position peaked at $229M in Q4 2022. 1,325 funds tracked by Wall St. Rank hold EW as of Q2 2026.

John Overdeck held 1,521,899 shares of Edwards Lifesciences worth $138M as of Q2 2026.
John Overdeck bought 470,364 Edwards Lifesciences shares in Q2 2026, an estimated $39.4M.
Edwards Lifesciences made up 0.1% of John Overdeck's portfolio in Q2 2026, its #225 holding.
John Overdeck first reported a position in Edwards Lifesciences in Q3 2013 and has held it in 42 quarters since.
John Overdeck's Edwards Lifesciences position peaked at $229M in Q4 2022.
1,325 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Two Sigma Investments's 13F filing for Q2 2026, filed 14 Aug 2026.